Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Functional B Cell Reconstitution Following Allogeneic Stem Cell Transplantation

Thuy N. Ho, MD, Maheen Khan, MS, Bennett Clark, Elizabeth Krieger, MD, Catherine H Roberts, PhD, Amir Ahmed Toor, MD

Blood (2020) 136 (Supplement 1): 40.

https://doi.org/10.1182/blood-2020-142799

Published: 2020

Journal Articles

Favorable Immune Reconstitution in Patients Administered Anti-Thymocyte Globulin (ATG) Early in the Course of Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation

Viktoriya Zelikson, BS, Natasha Raman, Anatevka Rebiero, MD, Elizabeth Krieger, MD, Catherine H Roberts, PhD, Gary Simmons, DO, Amir Ahmed Toor, MD

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-138581

Published: 2020

Journal Articles

Increased Inhibitory KIR-Ligand Interactions Confer Relapse Protection Following HLA Matched Unrelated Donor HCT for AML

Elizabeth Krieger, MD, Rehan Qayyum, MD, Amir Ahmed Toor, MD

Blood (2020) 136 (Supplement 1): 47.

https://doi.org/10.1182/blood-2020-134614

Published: 2020

Journal Articles

Variability in Killler Immunglobulin like Receptor Gene Expression As a Periodic Function of Gene Position on Chromosome 19

Elizabeth Krieger, MD, Urmila Sivagnanaling, Katherine Webb, Rehan Qayyum, MD, Amir Ahmed Toor, MBBS

Blood (2019) 134 (Supplement_1): 3608.

https://doi.org/10.1182/blood-2019-132270

Published: 2019

Journal Articles

Hematopoietic Cell Transplantation Donor Selection Reimagined: KIR-KIR Ligand Interactions and a Formalized Donor Risk Index Effective at Predicting Survival

Elizabeth Krieger, MD, Urmila Sivagnanaling, Katherine Webb, Dana Broadway, Catherine Roberts, PhD, John M. McCarty, MD, Christina M. Wiedl, DO, Rizwan Romee, MD PhD, Armand Keating, MD, Rehan Qayyum, Amir Ahmed Toor, MBBS

Blood (2019) 134 (Supplement_1): 4616.

https://doi.org/10.1182/blood-2019-129384

Published: 2019

NARROW

Functional B Cell Reconstitution Following Allogeneic Stem Cell Transplantation

Favorable Immune Reconstitution in Patients Administered Anti-Thymocyte Globulin (ATG) Early in the Course of Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation

Increased Inhibitory KIR-Ligand Interactions Confer Relapse Protection Following HLA Matched Unrelated Donor HCT for AML

Variability in Killler Immunglobulin like Receptor Gene Expression As a Periodic Function of Gene Position on Chromosome 19

Hematopoietic Cell Transplantation Donor Selection Reimagined: KIR-KIR Ligand Interactions and a Formalized Donor Risk Index Effective at Predicting Survival

Email alerts

ASH Publications

American Society of Hematology

Functional B Cell Reconstitution Following Allogeneic Stem Cell Transplantation

Favorable Immune Reconstitution in Patients Administered Anti-Thymocyte Globulin (ATG) Early in the Course of Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation

Increased Inhibitory KIR-Ligand Interactions Confer Relapse Protection Following HLA Matched Unrelated Donor HCT for AML

Variability in Killler Immunglobulin like Receptor Gene Expression As a Periodic Function of Gene Position on Chromosome 19

Hematopoietic Cell Transplantation Donor Selection Reimagined: KIR-KIR Ligand Interactions and a Formalized Donor Risk Index Effective at Predicting Survival

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only